GL:NYSEGlobe Life Inc. Analysis

Globe Life is trading around $152.96, just shy of its 20‑day SMA of $153.35 and comfortably above the $145.37 support level, while the 200‑day SMA sits near $140.98, underscoring a clear bullish trend. The RSI at 52.7 indicates neutral momentum and the MACD histogram is modestly negative, hinting at short‑term pressure despite the overall uptrend. Volume is on the rise and 30‑day volatility is about 21%, but a low beta of 0.5 suggests the stock moves less than the market. Fundamentals are solid: revenue grew 5.4% YoY to $6.07 B, profit margin sits near 19%, and free cash flow exceeds $1.3 B, supporting a modest dividend yield of 0.88% with an ultra‑low payout ratio of ~8%. The forward EPS of $16.62 and a forward P/E of 9.2 signal earnings expansion, while the DCF‑derived fair value of $240 implies roughly 14% upside. Analyst consensus is a “Buy” with a median target of $176, reinforcing the undervaluation thesis.